Immunic (IMUX) Short Interest Ratio & Short Volume → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free IMUX Stock Alerts $1.29 +0.01 (+0.78%) (As of 09:00 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Immunic Short Interest DataCurrent Short Volume2,820,000 sharesPrevious Short Volume2,880,000 sharesChange Vs. Previous Month-2.08%Dollar Volume Sold Short$3.55 millionShort Interest Ratio / Days to Cover5.7Last Record DateApril 30, 2024Outstanding Shares90,080,000 sharesPercentage of Shares Shorted3.13%Today's Trading Volume644 sharesAverage Trading Volume740,623 sharesToday's Volume Vs. Average0% Short Selling Immunic ? Sign up to receive the latest short interest report for Immunic and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIMUX Short Interest Over TimeIMUX Days to Cover Over TimeIMUX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingTrump’s Former Wingman Bets Big on AIOne of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here. Immunic Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,820,000 shares $3.55 million -2.1%N/A5.7 $1.26 4/15/20242,880,000 shares $3.77 million -5.0%N/A4.9 $1.31 3/31/20243,030,000 shares $4.00 million +22.7%N/A3.1 $1.32 3/15/20242,470,000 shares $3.24 million +11.3%N/A2.5 $1.31 2/29/20242,220,000 shares $3.25 million -11.9%N/A2.4 $1.47 2/15/20242,520,000 shares $3.38 million -2.7%N/A2.9 $1.34 Get the Latest News and Ratings for IMUX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,590,000 shares $3.08 million -20.6%N/A3.3 $1.19 1/15/20243,260,000 shares $4.17 million +48.2%N/A4.2 $1.28 12/31/20232,200,000 shares $3.30 million -6.4%N/A1.9 $1.50 12/15/20232,350,000 shares $3.53 million -15.2%N/A2.9 $1.50 11/30/20232,770,000 shares $3.30 million -6.4%N/A3.5 $1.19 11/15/20232,960,000 shares $2.96 million -9.5%N/A3.8 $1.00 10/31/20233,270,000 shares $3.47 million -24.7%N/A4.1 $1.06 10/15/20234,340,000 shares $5.25 million +77.9%N/A5.4 $1.21 9/30/20232,440,000 shares $3.59 million -2.4%N/A3 $1.47 9/15/20232,500,000 shares $3.58 million +4.6%N/A2.7 $1.43 8/31/20232,390,000 shares $3.99 million +11.7%N/A2.5 $1.67 8/15/20232,140,000 shares $3.66 million +7.5%N/A2.1 $1.71 7/31/20231,990,000 shares $4.80 million -2.0%N/A1.9 $2.41 7/15/20232,030,000 shares $5.14 million -6.5%N/A1.9 $2.53 6/30/20232,170,000 shares $5.45 million +6.9%N/A2.1 $2.51 6/15/20232,030,000 shares $3.35 million -12.9%N/A1.9 $1.65 5/31/20232,330,000 shares $3.84 million -28.3%N/A2 $1.65 5/15/20233,250,000 shares $5.72 million -11.0%N/A2.6 $1.76 4/30/20233,650,000 shares $6.06 million -14.7%N/A2.8 $1.66 4/15/20234,280,000 shares $6.12 million +3.1%N/A3 $1.43 3/31/20234,150,000 shares $6.18 million -5.7%N/A2.7 $1.49 3/15/20234,400,000 shares $7.22 million -21.7%N/A4.4 $1.64 2/28/20235,620,000 shares $11.13 million +4.9%N/A5.6 $1.98 2/15/20235,360,000 shares $11.36 million -10.2%N/A5.6 $2.12 1/31/20235,970,000 shares $14.33 million -13.9%N/A5.5 $2.40 1/15/20236,930,000 shares $10.67 million -2.0%N/A3.6 $1.54 12/30/20227,070,000 shares $9.90 million -1.7%N/A1.8 $1.40 12/15/20227,190,000 shares $8.63 million +2.1%N/A1.9 $1.20 11/30/20227,040,000 shares $9.43 million +0.7%N/A1.9 $1.34 11/15/20226,990,000 shares $10.35 million -0.9%N/A1.9 $1.48 10/31/20227,050,000 shares $12.48 million +92.6%N/A2.1 $1.77 10/15/20223,660,000 shares $36.71 million +418.7%N/A1.2 $10.03 9/30/2022705,600 shares $2.23 million -20.9%N/A0.8 $3.16 9/15/2022892,200 shares $3.57 million -3.2%N/A5.5 $4.00Democrats Push to Replace Dollar With Digital Coin, Control Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. IMUX Short Interest - Frequently Asked Questions What is Immunic's current short interest? Short interest is the volume of Immunic shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 2,820,000 shares of IMUX short. Learn More on Immunic's current short interest. What is a good short interest ratio for Immunic? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMUX shares currently have a short interest ratio of 6.0. Learn More on Immunic's short interest ratio. Is Immunic's short interest increasing or decreasing? Immunic saw a drop in short interest in April. As of April 30th, there was short interest totaling 2,820,000 shares, a drop of 2.1% from the previous total of 2,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Immunic's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Immunic: Abeona Therapeutics Inc (12.94%), Rezolute, Inc. (0.78%), Cellectar Biosciences, Inc. (7.85%), Adagene Inc. (0.04%), FibroGen, Inc. (6.96%), Corvus Pharmaceuticals, Inc. (3.69%), Citius Pharmaceuticals, Inc. (9.07%), PMV Pharmaceuticals, Inc. (6.93%), Coya Therapeutics, Inc. (1.41%), Relmada Therapeutics, Inc. (5.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Immunic stock? Short selling IMUX is an investing strategy that aims to generate trading profit from Immunic as its price is falling. IMUX shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immunic? A short squeeze for Immunic occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMUX, which in turn drives the price of the stock up even further. How often is Immunic's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMUX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ABEO Short Squeeze RZLT Short Squeeze CLRB Short Squeeze ADAG Short Squeeze FGEN Short Squeeze CRVS Short Squeeze CTXR Short Squeeze PMVP Short Squeeze COYA Short Squeeze RLMD Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMUX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishingis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders